Caas Capital Management LP Organon & Co. Transaction History

Caas Capital Management LP

  • $836 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$10.95 - $17.32 $113,879 - $180,128
10,400 New
10,400 $149,000
Q4 2021

Feb 14, 2022
SELL
$28.67 - $37.13 $15.1 Million - $19.5 Million
-526,001 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$28.63 - $35.64 $12.8 Million - $15.9 Million
446,638 Added 562.78%
526,001 $17.2 Million
Q2 2021

Aug 16, 2021
BUY
$28.45 - $38.0 $2.26 Million - $3.02 Million
79,363 New
79,363 $2.4 Million

Others Institutions Holding OGN

# of Institutions
791
Shares Held
193M
Call Options Held
1.71M
Put Options Held
865K
View Full List

About Organon & Co.

OGN Quotes by TradingView
  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.89B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Caas Capital Management LP Portfolio

Follow Caas Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Caas Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email